Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Paragraph 8 Sgb V On The Active Ingredient Vedolizumab, Atc L04aa33 For The Period 01.07.2025 30.2027 2025-11-18
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Dolutegravir + Rilpivirin, Atc J05ar21 For The Time 01.07.2025 30.2027 2025-11-18
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Lamivudin + Abacavir + Dolutegravir, Atc J05ar13 For The Time 01.07.2025 30.2027 2025-11-18
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Denosumab, Atc M05bx04 For The Time 01.07.2025 30.06.2026 (plus Extension Option 1x 12 Months) 2025-11-18
Germany Openhouser Discount Contracts 202406 2025-11-18
Germany Delivery Of Rust Sticks 120 Mm public Tender 2025-11-18
Germany Open House Pharmaceutical Dact Treaties Formoterol, Glycopyrronium Bromide And Budesonide, Atc R03al11 2025-11-18
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Goliumumab, Atc L04ab06 For The Time 01.07.2025 30.06.2027 2025-11-18
Germany Open House Pharmaceutical Department Treaties Iron (iii) Derisomaltosis, Atc B03ac08 2025-11-18
Germany Open House Pharmaceutical Discount Contracts In Accordance With Section 130a Par. 8c Sgb V Eribulin, Atc L01xx41 2025-11-18
Whats app